GO:0005091 guanyl-nucleotide exchange factor adaptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005091 (guanyl-nucleotide exchange factor adaptor activity) describes a molecular function in which a protein physically brings together a guanyl-nucleotide exchange factor (GEF) and one or more partner proteins so they can act in a coordinated way.
• Adaptor-mediated GEF regulation is best documented for Rho/Rap-family GTPases, where proteins such as Crk, APS, MYO18A and C5orf51 assemble or stabilize GEF-containing complexes.
• The function is mechanistically distinct from GEF catalytic activity itself: the adaptor does not necessarily exchange nucleotide, but scaffolds and localizes the exchange reaction.
• Dysregulated GEF-adaptor complexes contribute to cancer cell migration, invasion, immune signaling and cell-cycle progression.
• CRISPR knockout, point-mutation, knock-in and overexpression models are the primary tools for testing whether a candidate adaptor is causally required for GEF-dependent signaling.
• EDITGENE provides end-to-end CRISPR cell model generation and library screening to dissect GO:0005091-dependent pathways.
Description
GO:0005091, guanyl-nucleotide exchange factor adaptor activity, is a molecular function term that captures the binding activity of a molecule which brings together a guanyl-nucleotide exchange factor (GEF) and one or more other proteins, permitting them to function in a coordinated way. In practical terms, this activity is what allows a scaffold or adaptor protein to position a GEF next to its GTPase substrate and its upstream regulators, converting a diffuse biochemical potential into a spatially and temporally controlled signal. Because GEFs activate small GTPases such as Rho, Rap and Rab family members, adaptor-dependent assembly of GEF complexes is central to cell migration, adhesion, immune synapse formation and membrane trafficking. The term is experimentally important because many GEFs are autoinhibited and require adaptor binding to become active. A classic example is the adaptor protein APS, which binds the NH2-terminal autoinhibitory domain of the GEF Vav3 and augments its activity, directly illustrating adaptor-dependent GEF activation. Similarly, Crk proteins activate the Rap1 GEF C3G through segregated adaptor-dependent and adaptor-independent mechanisms, showing that adaptor function can be separated genetically from catalytic GEF function. These studies make GO:0005091 a useful annotation for any protein that scaffolds a GEF complex rather than catalyzing nucleotide exchange itself. For researchers, GO:0005091 provides a framework to ask whether a candidate protein acts as a GEF adaptor, how that adaptor is regulated, and whether disrupting the adaptor-GEF interface alters downstream GTPase signaling. This article summarizes the definition, mechanism, key genes, disease links and CRISPR-based research methods relevant to GO:0005091, using only verified published literature.
guanyl-nucleotide exchange factor adaptor activity At A Glance
| GO ID | GO:0005091 |
|---|---|
| GO term | guanyl-nucleotide exchange factor adaptor activity |
| Ontology | molecular_function |
| Synonym | none listed in QuickGO |
| Major function | Binds a guanyl-nucleotide exchange factor and one or more other proteins to permit coordinated function |
| Functional class | Adaptor/scaffolding activity acting on GEF-containing complexes |
| Representative GTPase systems | Rho, Rap and Rab family GTPases |
| Representative adaptors/GEFs | APS-Vav3, Crk-C3G, MYO18A, C5orf51-MON1-CCZ1 |
| Disease relevance | Cancer cell migration and invasion, immune signaling, cell-cycle control |
What Is GO:0005091?
GO:0005091 is defined by QuickGO as the binding activity of a molecule that brings together a guanyl-nucleotide exchange factor and one or more other proteins, permitting them to function in a coordinated way. In other words, it is an adaptor or scaffolding function whose defining feature is the simultaneous or sequential binding of a GEF and additional protein partners. The term does not require that the adaptor itself catalyze GDP-to-GTP exchange; instead, it describes the binding activity that organizes a GEF-containing complex. This distinguishes GO:0005091 from GEF catalytic activity and from generic protein binding, because the functional outcome is coordinated GEF-dependent signaling.
Why Is guanyl-nucleotide exchange factor adaptor activity Important in Cell Biology?
GO:0005091 matters because it explains how GEFs achieve specificity and spatial control in cells. Free GEFs are often autoinhibited or too broadly distributed to generate precise GTPase activation, so adaptor proteins that bind both the GEF and additional partners are required to assemble functional signaling modules. This adaptor function is directly implicated in cancer cell migration and invasion through Rho GTPase switches, in mechanoresponses of the Hippo pathway via RAP2, in RAB7A-dependent mitophagy through the MON1-CCZ1 complex, in T-cell signaling through Vav-family GEFs, and in cell-cycle progression through ARHGEF17/TEM4. Because these processes are experimentally tractable with CRISPR models, GO:0005091 is a high-value annotation for target discovery and mechanism-of-action studies.
• Defines how adaptor proteins scaffold GEF-GTPase signaling modules rather than catalyzing exchange directly.
• Explains autoinhibition relief for GEFs such as Vav3, where APS binding to the NH2-terminal autoinhibitory domain augments activity.
• Links GEF adaptor function to cancer cell migration and invasion through Rho GTPase switches.
• Connects adaptor-GEF complexes to mechanotransduction and the Hippo pathway via RAP2.
• Implicates GEF adaptor complexes in RAB7A localization and stability during mitophagy.
• Provides a mechanistic basis for T-cell signaling defects involving Vav-family GEFs.
• Connects ARHGEF17/TEM4 adaptor function to G1 progression and cell-cycle control.
• Supports target validation using CRISPR knockout, point mutation, knock-in and overexpression models.
• Enables functional genomics screens for modifiers of GEF-adaptor signaling.
• Guides design of drugs that disrupt adaptor-GEF interfaces rather than catalytic sites.
Molecular Mechanism of guanyl-nucleotide exchange factor adaptor activity
Adaptor binding to the GEF autoinhibitory domain
In simple terms: An adaptor protein can grab a GEF and release its built-in brake.
Many GEFs contain autoinhibitory domains that keep them inactive until a partner binds. The adaptor protein APS binds the NH2-terminal autoinhibitory domain of the GEF Vav3 and augments its activity, providing a direct example of adaptor-dependent GEF activation. This binding event is the defining step of GO:0005091 because it brings the GEF into a conformation or complex competent for downstream signaling.
Scaffolding of GEF and GTPase partners
In simple terms: The adaptor acts like a molecular clamp that holds the GEF and its target GTPase close together.
Crk proteins activate the Rap1 GEF C3G through segregated adaptor-dependent and adaptor-independent mechanisms, showing that adaptor function can be genetically separated from catalytic GEF activity. This segregation implies that the adaptor module positions C3G relative to Rap1 and other partners, permitting coordinated GTPase activation. Similar scaffolding logic applies to Rho GTPase switches controlling cell migration and invasion.
Localization and complex assembly at membranes
In simple terms: The adaptor helps move the GEF to the right place inside the cell.
Adaptor proteins can localize GEF complexes to specific membranes or compartments. C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy, illustrating how an adaptor-containing complex directs a GTPase regulatory module to the correct compartment. MYO18A is an unusual myosin that can serve as a scaffold for signaling complexes, consistent with adaptor-like coordination of GEF-dependent events.
Regulation by upstream signals and mechanotransduction
In simple terms: Outside signals can switch the adaptor-GEF module on or off.
RAP2 mediates mechanoresponses of the Hippo pathway, showing that GEF-adaptor modules can be controlled by mechanical cues. YAP controls cell migration and invasion through a Rho GTPase switch, linking transcriptional and cytoskeletal programs to GEF-adaptor-dependent GTPase activation. These examples indicate that GO:0005091 activity is not constitutive but is tuned by upstream signaling and mechanical context.
Cell-cycle and immune-specific adaptor functions
In simple terms: Different cells use different adaptor-GEF pairs for division and immune signaling.
ARHGEF17/TEM4 regulates the cell cycle through control of G1 progression, demonstrating that a GEF with adaptor-like coordination functions is required for normal proliferation. Vav-family proteins are central to T-cell signaling, where adaptor-dependent assembly of GEF complexes couples antigen receptor engagement to cytoskeletal and transcriptional responses. Together these examples show that GO:0005091 supports both proliferative and immune-specific signaling outputs.
Key Genes Involved in GO:0005091 guanyl-nucleotide exchange factor adaptor activity
The following genes and proteins are experimentally linked to guanyl-nucleotide exchange factor adaptor activity or to GEF-adaptor complexes in published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VAV3 | GEF whose NH2-terminal autoinhibitory domain is bound by APS adaptor | Adaptor-dependent GEF activation model |
| APS (SH2B2) | Adaptor that binds Vav3 autoinhibitory domain and augments activity | Direct example of GO:0005091 function |
| CRK | Adaptor that activates the Rap1 GEF C3G | Segregated adaptor-dependent and independent GEF activation |
| C3G (RAPGEF1) | Rap1 guanine nucleotide exchange factor | Target of Crk adaptor-dependent activation |
| RAP2 | GTPase mediating mechanoresponses of the Hippo pathway | Links GEF-adaptor signaling to mechanotransduction |
| YAP | Transcriptional regulator controlling migration and invasion via Rho GTPase switch | Connects GEF-adaptor signaling to cancer cell behavior |
| MYO18A | Unusual myosin with scaffold/adaptor functions | Potential coordinator of GEF-containing complexes |
| C5orf51 | Component of the MON1-CCZ1 complex controlling RAB7A | Adaptor-containing complex in mitophagy |
| MON1 | Subunit of MON1-CCZ1 complex | RAB7A regulation during mitophagy |
| CCZ1 | Subunit of MON1-CCZ1 complex | RAB7A regulation during mitophagy |
| RAB7A | Late endosomal GTPase | GTPase controlled by adaptor-containing complex |
| ARHGEF17/TEM4 | GEF regulating G1 progression | Cell-cycle control through GEF function |
| VAV1 | Vav-family GEF in T-cell signaling | Immune adaptor-GEF signaling |
| VAV2 | Vav-family GEF | Immune and cytoskeletal signaling |
| RAP1 | Small GTPase activated by C3G | Downstream effector of adaptor-GEF module |
| RHOA | Rho-family GTPase | Cytoskeletal output of GEF-adaptor signaling |
| CDC42 | Rho-family GTPase | Cytoskeletal and polarity output |
How Is guanyl-nucleotide exchange factor adaptor activity Regulated?
GO:0005091 activity is regulated at multiple levels. Autoinhibition of GEFs can be relieved by adaptor binding, as shown for APS binding to the Vav3 NH2-terminal autoinhibitory domain. Adaptor-dependent and adaptor-independent mechanisms can coexist for the same GEF, as demonstrated for Crk-mediated activation of C3G. Upstream mechanical cues can control GEF-adaptor modules through RAP2 in the Hippo pathway, and transcriptional programs driven by YAP can feed back on Rho GTPase switches that depend on GEF-adaptor coordination. Cell-cycle progression provides another layer of regulation, with ARHGEF17/TEM4 controlling G1 progression. Finally, adaptor-containing complexes such as MON1-CCZ1 regulate RAB7A localization and stability during mitophagy, showing that membrane trafficking inputs also modulate this activity.
guanyl-nucleotide exchange factor adaptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| YAP | Cancer cell migration and invasion | Knockout and overexpression in cancer cell lines |
| C3G (RAPGEF1) | Rap1-dependent cytoskeletal remodeling | Point mutation of Crk-binding interface |
| VAV3 | Immune signaling and GEF autoinhibition | Knock-in of APS-binding-deficient mutant |
| ARHGEF17/TEM4 | Cell-cycle progression and proliferation | Knockout with cell-cycle profiling |
| C5orf51 | Mitophagy and RAB7A trafficking | Tagged knock-in for localization studies |
Cancer cell migration, invasion and metastasis
GEF-adaptor signaling is directly linked to cancer cell migration and invasion. YAP controls cell migration and invasion through a Rho GTPase switch, implicating adaptor-dependent GEF activation in metastatic behavior. Crk-mediated activation of the Rap1 GEF C3G provides a mechanism by which adaptor proteins can drive cytoskeletal remodeling relevant to tumor cell dissemination. These findings support targeting adaptor-GEF interfaces in cancer research.
Immune signaling and immunodeficiency
Vav-family proteins are central to T-cell signaling, where GEF activity must be coordinated with adaptor proteins to couple antigen receptor engagement to downstream responses. APS binding to Vav3 augments GEF activity, illustrating how adaptor dysfunction could alter immune cell activation. This makes GO:0005091 relevant to immune signaling disorders and to the design of immunomodulatory experiments.
Cell-cycle control and proliferative disorders
ARHGEF17/TEM4 regulates the cell cycle through control of G1 progression, linking GEF function to proliferation. Because adaptor proteins can determine where and when GEFs act, disruption of GO:0005091-dependent coordination could contribute to uncontrolled proliferation. This provides a rationale for studying adaptor-GEF modules in proliferative diseases.
Membrane trafficking and mitophagy-related pathology
C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy, connecting adaptor-containing complexes to autophagic and lysosomal pathways. MYO18A scaffold functions may similarly coordinate trafficking-related GEF complexes. These links suggest that GO:0005091-dependent complexes are relevant to diseases involving defective mitophagy or endolysosomal trafficking.
From guanyl-nucleotide exchange factor adaptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is the candidate adaptor required for GEF-dependent signaling? | CRISPR knockout cell line |
| Does a specific adaptor-GEF interface mediate activation? | Point-mutation knock-in of the binding interface |
| Where does the adaptor-GEF complex localize? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression phenocopy GTPase activation? | Stable overexpression cell line |
| Which genes modify the adaptor-GEF phenotype? | CRISPR library screening |
| Is the adaptor function conserved across cell types? | Panel of knockout lines in multiple backgrounds |
How to Study the guanyl-nucleotide exchange factor adaptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function phenotype | Testing requirement for adaptor-GEF signaling |
| Point-mutation knock-in | Specific interface contribution | Separating adaptor-dependent and independent GEF activation |
| Tagged knock-in | Protein localization and complex assembly | Imaging adaptor-GEF complexes |
| Overexpression | Gain-of-function phenotype | Testing sufficiency of GEF-adaptor modules |
| CRISPR library screening | Genetic modifiers of phenotype | Discovering regulators of GEF-adaptor signaling |
| Proteomics / interactome | Protein-protein interactions | Mapping adaptor-GEF complexes |
| Cell migration and invasion assays | Cytoskeletal and invasive behavior | Linking GEF-adaptor function to cancer phenotypes |
| Cell-cycle profiling | Proliferation and G1 progression | Assessing ARHGEF17/TEM4 function |
CRISPR knockout and phenotypic profiling
Knockout of candidate adaptor or GEF genes followed by migration, invasion or proliferation assays can test causality. YAP-dependent migration and invasion through a Rho GTPase switch provides a template for such experiments. ARHGEF17/TEM4 knockout with cell-cycle profiling illustrates how G1 progression can be assessed.
Point-mutation and knock-in dissection of interfaces
Point mutations that disrupt adaptor-GEF binding can separate adaptor-dependent from adaptor-independent functions. Crk-mediated activation of C3G was dissected using segregated adaptor-dependent and adaptor-independent mechanisms, a strategy transferable to knock-in models. APS binding to the Vav3 autoinhibitory domain can be mutated to test its contribution to GEF activation.
Imaging and localization studies
Tagged knock-in of adaptor or GEF genes enables live-cell imaging of complex localization. C5orf51 tagging has been used to study MON1-CCZ1-dependent RAB7A localization during mitophagy. MYO18A scaffold behavior can be imaged to assess its role in coordinating signaling complexes.
Proteomics and interactome mapping
Affinity purification or proximity labeling of adaptor proteins can identify GEF and GTPase partners. The Crk-C3G interaction and APS-Vav3 interaction provide validated positive controls for such workflows. Complex members such as MON1 and CCZ1 can be monitored by proteomics during mitophagy.
How CRISPR Can Be Used to Study GO:0005091 guanyl-nucleotide exchange factor adaptor activity
Knockout
CRISPR knockout of candidate adaptor or GEF genes is the primary method to test necessity. YAP knockout affects migration and invasion through a Rho GTPase switch, providing a validated readout. ARHGEF17/TEM4 knockout impairs G1 progression, demonstrating cell-cycle phenotypes. Knockout of adaptor genes such as CRK or SH2B2 can be used to test GEF activation dependence.
Point Mutation
Point-mutation knock-in can disrupt specific adaptor-GEF interfaces while preserving protein expression. The segregated adaptor-dependent and adaptor-independent activation of C3G by Crk provides a conceptual template for such mutations. Mutating the APS-binding region of Vav3 can test autoinhibitory domain engagement.
Knock-in
Tagged knock-in of adaptor or GEF genes enables localization and interaction studies. C5orf51 tagging has been used to track MON1-CCZ1-dependent RAB7A during mitophagy. MYO18A knock-in tags can reveal scaffold dynamics in signaling complexes. Fluorescent knock-in of RAP2 or YAP can link localization to mechanotransduction.
Overexpression
Overexpression of adaptor or GEF constructs can test sufficiency and dominant-active effects. Overexpression of YAP or Rho GTPase pathway components can phenocopy migration and invasion phenotypes. RAP2 overexpression can modulate Hippo pathway mechanoresponses. Overexpression of Vav3 or APS can amplify GEF-dependent signaling.
How EDITGENE Supports guanyl-nucleotide exchange factor adaptor activity Research
Researchers studying guanyl-nucleotide exchange factor adaptor activity-related genes often need to determine whether a candidate gene is causally involved in GEF-dependent signaling, which interface mediates the effect, and how the complex localizes and is regulated. EDITGENE provides publication-ready CRISPR cell models and screening services tailored to these questions.
Contact EDITGENE today to design your custom CRISPR model for guanyl-nucleotide exchange factor adaptor activity research.
Frequently Asked Questions About guanyl-nucleotide exchange factor adaptor activity
What is guanyl-nucleotide exchange factor adaptor activity?
It is the binding activity of a molecule that brings together a guanyl-nucleotide exchange factor and one or more other proteins so they can function in a coordinated way, annotated as GO:0005091.
What is GO:0005091?
GO:0005091 is the Gene Ontology molecular function term for guanyl-nucleotide exchange factor adaptor activity, defined as binding that assembles a GEF with partner proteins.
What genes are involved in guanyl-nucleotide exchange factor adaptor activity?
Genes include VAV3, APS/SH2B2, CRK, C3G/RAPGEF1, RAP2, YAP, MYO18A, C5orf51, MON1, CCZ1, RAB7A, ARHGEF17/TEM4, VAV1 and VAV2.
How is guanyl-nucleotide exchange factor adaptor activity different from GEF catalytic activity?
The adaptor activity is a binding function that organizes a GEF-containing complex, whereas GEF catalytic activity directly catalyzes GDP-to-GTP exchange; the two can be genetically separated, as shown for Crk-C3G.
Which diseases are linked to GEF adaptor activity?
It is linked to cancer cell migration and invasion, immune signaling defects, cell-cycle dysregulation and mitophagy-related trafficking defects.
How do I study guanyl-nucleotide exchange factor adaptor activity with CRISPR?
Use knockout to test necessity, point-mutation knock-in to disrupt specific interfaces, tagged knock-in for localization and overexpression for sufficiency, as demonstrated in YAP, ARHGEF17/TEM4, Crk-C3G and APS-Vav3 studies.
What is the role of APS in GEF adaptor activity?
APS binds the NH2-terminal autoinhibitory domain of the GEF Vav3 and augments its activity, providing a direct example of adaptor-dependent GEF activation.
How does Crk regulate C3G?
Crk proteins activate the Rap1 GEF C3G through segregated adaptor-dependent and adaptor-independent mechanisms.
Is guanyl-nucleotide exchange factor adaptor activity involved in cell migration?
Yes, YAP controls cell migration and invasion through a Rho GTPase switch, implicating GEF-adaptor signaling in migration.
What experimental models are best for GO:0005091 research?
CRISPR knockout, point-mutation knock-in, tagged knock-in, overexpression cell lines and CRISPR library screens are the most informative models.
Conclusion
GO:0005091, guanyl-nucleotide exchange factor adaptor activity, defines the binding function that assembles GEFs with partner proteins into coordinated signaling modules. Published work on APS-Vav3, Crk-C3G, RAP2-Hippo, C5orf51-MON1-CCZ1, Vav-family proteins and ARHGEF17/TEM4 shows that this activity controls migration, invasion, immune signaling, cell-cycle progression and membrane trafficking. Because these mechanisms are genetically tractable, CRISPR-based knockout, point-mutation, knock-in, overexpression and library screening approaches are well suited to dissect GO:0005091-dependent pathways and to validate therapeutic targets.
References
- 1. Shah SR et al.. 2025. YAP controls cell migration and invasion through a Rho GTPase switch.. Sci Signal 18(888):eadu3794 PMID: 40424361
- 2. Meng Z et al.. 2018. RAP2 mediates mechanoresponses of the Hippo pathway.. Nature 560(7720):655-660 PMID: 30135582
- 3. Yan BR et al.. 2022. C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.. Autophagy 18(4):829-840 PMID: 34432599
- 4. Rodríguez-Blázquez A et al.. 2023. Crk proteins activate the Rap1 guanine nucleotide exchange factor C3G by segregated adaptor-dependent and -independent mechanisms.. Cell Commun Signal 21(1):30 PMID: 36737758
- 5. Buschman MD et al.. 2018. MYO18A: An unusual myosin.. Adv Biol Regul 67:84-92 PMID: 28942352
- 6. Tybulewicz VL. 2005. Vav-family proteins in T-cell signalling.. Curr Opin Immunol 17(3):267-74 PMID: 15886116
- 7. Prifti DK et al.. 2025. ARHGEF17/TEM4 regulates the cell cycle through control of G1 progression.. J Cell Biol 224(3) PMID: 39903211
- 8. Yabana N et al.. 2002. Adaptor protein APS binds the NH2-terminal autoinhibitory domain of guanine nucleotide exchange factor Vav3 and augments its activity.. Oncogene 21(50):7720-9 PMID: 12400014
